Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z1ID
|
||||
Former ID |
DNC013795
|
||||
Drug Name |
Furan-2-ylmethylcarbamic Acid Biphenyl-3-yl Ester
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529498] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H15NO3
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C2=CC(=CC=C2)OC(=O)NCC3=CC=CO3
|
||||
InChI |
1S/C18H15NO3/c20-18(19-13-17-10-5-11-21-17)22-16-9-4-8-15(12-16)14-6-2-1-3-7-14/h1-12H,13H2,(H,19,20)
|
||||
InChIKey |
OLMUNVAXPITDSI-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529498] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.